Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.4M
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
110M
-
Shares change
-
+16M
-
Total reported value, excl. options
-
$4.81B
-
Value change
-
+$735M
-
Put/Call ratio
-
0.36
-
Number of buys
-
128
-
Number of sells
-
-111
-
Price
-
$43.60
Significant Holders of Acadia Healthcare Company, Inc. - Common Stock (ACHC) as of Q1 2017
289 filings reported holding ACHC - Acadia Healthcare Company, Inc. - Common Stock as of Q1 2017.
Acadia Healthcare Company, Inc. - Common Stock (ACHC) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 110M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (11.9M shares), WELLINGTON MANAGEMENT GROUP LLP (9.55M shares), JPMORGAN CHASE & CO (7.71M shares), VANGUARD GROUP INC (5.74M shares), WELLS FARGO & COMPANY/MN (5.68M shares), BlackRock Inc. (5.15M shares), GOLDMAN SACHS GROUP INC (4.27M shares), BAIN CAPITAL INVESTORS LLC (3.45M shares), Aristotle Capital Management, LLC (3.21M shares), and Aristotle Capital Management, LLC (3.21M shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.